Protocol to request
Sustainability of oral therapy (IVA/LUM or IVA/TEZ) on NLRP3-stimulated cytokine production in PBMCs
Research advance
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
Heledd H Jarosz-Griffiths et al.
DOI: 10.7554/eLife.54556